Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.33 |
| ▸ | TLR2 | O60603 | 1/20 | 0.32 |
| ▸ | CASP2 | P42575 | 1/20 | 0.32 |
| ▸ | FAAH | O00519 | 2/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.31 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | GLS2 | Q9UI32 | 2/20 | 0.30 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24787484 | 0.92 | TLR2 (0.40) | DNM1TLR2ALDH1A1MAPT | |
| SCHEMBL25681904 | 0.92 | TLR2 (0.40) | DNM1TLR2ALDH1A1MAPT | |
| SCHEMBL19681644 | 0.92 | MEN1 (0.32) | DNM1EPHX2TRPV1MAPT | |
| SCHEMBL24787486 | 0.91 | DNM1 (0.31) | DNM1TLR2CASP2 | |
| SCHEMBL25681831 | 0.86 | FAAH (0.36) | DNM1CASP2FAAHEPHX2NAAA | |
| SCHEMBL25682074 | 0.85 | DNM1 (0.35) | DNM1CASP2FAAHEPHX2NAAA | |
| SCHEMBL25681951 | 0.83 | DNM1 (0.42) | DNM1CASP2FAAHEPHX2NAAA | |
| SCHEMBL19681645 | 0.78 | FAAH (0.35) | DNM1CASP2FAAHEPHX2NAAA | |
| SCHEMBL21965331 | 0.78 | DNM1 (0.34) | DNM1CASP2FAAHEPHX2NAAA | |
| SCHEMBL19681579 | 0.78 | GLS2 (0.39) | TLR2FAAHEPHX2GLS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022261185-A1 | POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS, AND METHODS OF USE THEREOF | RECODE THERAPEUTICS, INC. (US) | 2022-12-15 | — | — | WO | disclosed |